Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2014
05/15/2014US20140135396 Treatment of Acetaminophen-Induced Liver Damage by the Administration of Modulators of Nitric Oxide
05/15/2014US20140135395 Gastric retentive gabapentin dosage forms and methods for using same
05/15/2014US20140135392 Methods for the treatment of sialorrhea
05/15/2014US20140135391 Method for manufacturing refined chlorogenic acids composition
05/15/2014US20140135389 Quinone based nitric oxide donating compounds
05/15/2014US20140135387 Use of equol of treating androgen mediated diseases
05/15/2014US20140135386 Method for treating atherosclerosis or restenosis using microtubule stabilizing agent
05/15/2014US20140135385 Ryanodine receptor inhibitors for treatment of t-cell mediated disorders
05/15/2014US20140135381 Small molecule conjugates for intracellular delivery of biologically active compounds
05/15/2014US20140135380 Small molecule conjugates for intracellular delivery of nucleic acids
05/15/2014US20140135379 Method of fixing and expressing physiologically active substance
05/15/2014US20140135378 Targeting en2, pax2, and/or defb1 for treatment of prostate conditions
05/15/2014US20140135377 Combination therapy
05/15/2014US20140135376 Nanogels
05/15/2014US20140135375 Edible Transgenic Plants as Oral Delivery Vehicles for RNA-Based Therapeutics
05/15/2014US20140135373 Novel esters of n-acylated derivatives of amino acids and isosorbide, method for preparing same, and use thereof in cosmetics and as drug
05/15/2014US20140135372 Compositions and methods of treatment of inflammatory skin conditions using allantoin
05/15/2014US20140135370 Treating cancer with an hsp90 inhibitory compound
05/15/2014US20140135368 Synthesis of intermediates for preparing anacetrapib and derivatives thereof
05/15/2014US20140135367 Use of Epothilone D in Treating Tau-Associated Diseases Including Alzheimer's Disease
05/15/2014US20140135363 Proton pump inhibitor for use in a method of treating dermatological diseases in canine
05/15/2014US20140135360 Aryl Derivatives And Uses Thereof
05/15/2014US20140135359 Methods of designing, preparing, and using novel protonophores
05/15/2014US20140135358 Use of FK506 for the Treatment of Pulmonary Arterial Hypertension
05/15/2014US20140135357 Dose regime for camptothecin derivatives
05/15/2014US20140135355 Abuse-Resistant Controlled-Release Opioid Dosage Form
05/15/2014US20140135354 Tetrandrine pharmaceutical formulations and method
05/15/2014US20140135352 Tablet having improved elution properties
05/15/2014US20140135350 Sustained-release dosage forms of ruxolitinib
05/15/2014US20140135349 Aqueous Compositions
05/15/2014US20140135348 Uses of dpp iv inhibitors
05/15/2014US20140135343 Aripiprazole medicament formulation and preparation method therefor
05/15/2014US20140135342 Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitors
05/15/2014US20140135340 High Drug Load Tablet
05/15/2014US20140135337 Induction of immune tolerance by using methotrexate
05/15/2014US20140135336 Triazolopyridazine
05/15/2014US20140135335 Spiro bicyclic oxalamide compounds for the treatment of hepatitis c
05/15/2014US20140135332 Aromatic amides and uses thereof
05/15/2014US20140135331 Thiazole and thiadiazole compounds for inflammation and immune-related uses
05/15/2014US20140135330 Oxazolidin-2-one-Pyrimidine Derivatives
05/15/2014US20140135329 Pyridine and Pyrazine derivative for the Treatment of CF
05/15/2014US20140135326 Method of treatment of aggression
05/15/2014US20140135324 Rapamycin Derivative or an Impdh Inhibitor for Treating Polycystic Kidney Disease
05/15/2014US20140135320 Heteroaryl derivatives and uses thereof
05/15/2014US20140135309 Sulfoximine substituted quinazolines for pharmaceutical compositions
05/15/2014US20140135308 Benzoxepin pi3k inhibitor compounds and methods of use
05/15/2014US20140135306 Hdyroxy substituted isoquinolinone derivatives
05/15/2014US20140135303 Hazardous Agent Injection System
05/15/2014US20140135301 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
05/15/2014US20140135300 Acetamide Stereoisomer
05/15/2014US20140135299 Enema composition for treatment of ulcerative colitis having long term stability
05/15/2014US20140135298 Mutation mimicking compounds that bind to the kinase domain of egfr
05/15/2014US20140135296 Methods of treating autophagy-associated disorders and related pharmaceutical compositions, diagnostics, screening techniques and kits
05/15/2014US20140135289 Method for preventing brain atrophy
05/15/2014US20140135288 Selecting use of proteasome inhibitors based on nf-kb2 sequence
05/15/2014US20140135286 Compositions and methods for inhibiting adhesion formation
05/15/2014US20140135284 Composition of aqueous buffer solution for the treatment of cellular environment and ion channels and methods for using same
05/15/2014US20140135283 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans
05/15/2014US20140135282 Pharmaceutical composition for use in inhibiting recurrence, aggravation and metastasis of hepatocarcinoma
05/15/2014US20140135259 Treatment of hepatitis c virus
05/15/2014US20140135256 Treatment of extracellular matrix to reduce inflammation
05/15/2014US20140134753 Methods for treating transthyretin amyloid diseases
05/15/2014US20140134283 Compositions and Methods for Affecting Mental State and Body Composition
05/15/2014US20140134282 Nitrooxy alkanoic acids and derivatives thereof in feed for reducing methane emission in ruminants, and/or to improve ruminant performance
05/15/2014US20140134281 Functional formulation
05/15/2014US20140134280 Extracts of cynanchum sp. and active ingredients contained therein in use of arthritis treatment
05/15/2014US20140134276 Anti-tumor drug, medicament, composition, and use thereof
05/15/2014US20140134275 Therapeutic combinations for use in neoplasia
05/15/2014US20140134274 Selective androgen receptor modulator and chemotherapeutic agent for treating muscle wasting in cancer patients
05/15/2014US20140134272 Methods of enhancing wound healing
05/15/2014US20140134265 Tec family kinase inhibitor adjuvant therapy
05/15/2014US20140134262 Method of treating atherosclerosis in high triglyceride subjects
05/15/2014US20140134261 Pharmaceutical Compositions Comprising Capsaicin Esters for Treating Pain and Cold Sores
05/15/2014US20140134260 Cationic lipids and methods for the delivery of therapeutic agents
05/15/2014US20140134259 Stable oral benzimidazole compositions and process of preparation thereof
05/15/2014US20140134257 Methods of treating melanoma
05/15/2014US20140134256 Drug Microparticles
05/15/2014US20140134254 Method for producing powders for inhalation
05/15/2014US20140134253 Dry powder fosfomycin/tobramycin formulation for inhalation
05/15/2014US20140134252 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
05/15/2014US20140134251 Pharmaceutical formulations and methods for treating respiratory tract infections
05/15/2014US20140134250 Oxymorphone controlled release formulations
05/15/2014US20140134248 Pharmaceutical compositions
05/15/2014US20140134247 Pharmaceutical composition
05/15/2014US20140134246 Rapid dissolve tablet compositions for vaginal administration
05/15/2014US20140134245 Ibuprofen chewable tablet
05/15/2014US20140134244 Antifungal compositions with improved bioavailability
05/15/2014US20140134243 Compositions for the Treatment of CNS-Related Conditions
05/15/2014US20140134239 Compositions and methods for treatment of the side-effects associated with administration of cancer chemotherapeutic agents
05/15/2014US20140134238 Tannin-chitosan composites
05/15/2014US20140134237 Type i interferon mimetics as therapeutics for cancer, viral infections, and multiple sclerosis
05/15/2014US20140134236 Individualized cancer therapy
05/15/2014US20140134233 SUPPRESSORS OF CpG OLIGONUCLEOTIDES AND METHODS OF USE
05/15/2014US20140134230 Transdermal therapeutic system
05/15/2014US20140134228 Chewable wafers containing lipid supplements for maintaining health and the treatment of acute and chronic disorders
05/15/2014US20140134226 Compositions and methods for inhibiting bone growth
05/15/2014US20140134225 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
05/15/2014US20140134210 Composition containing antibiotics and lysophosphatidylcholine for boosting immunity or treatment of bacterial infections
05/15/2014US20140134206 Inflammation and immunity treatments
05/15/2014US20140134188 Methods for P2RY5 Mediated Regulation of Hair Growth and Mutants Thereof
1 ... 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 ... 7860